Search research articles
Contact Us
Filters
Showing results (171-180 of 251) with videos related to
Page
of 26
Sort By:
Clinical Rheumatology
|
June 1, 1993
Rheumatoid arthritis as a cause of cardiac compression. Favourable long-term outcome of pericardiectomy
M Hakala, T Pettersson, M Tarkka, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix
R Lahesmaa, M Skurnik, M Vaara, et al.
Rheumatology (Oxford, England)
|
April 6, 2002
Campylobacter-triggered reactive arthritis: a population-based study
T Hannu, L Mattila, H Rautelin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1994
Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes
M Halme, P Maasilta, H Repo, et al.
Annals of the Rheumatic Diseases
|
August 1, 1996
Clinical significance of antibodies against oxidised low density lipoprotein in early RA
L Paimela, T Helve, M Leirisalo-Repo, et al.
Annals of the Rheumatic Diseases
|
December 15, 2000
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis
L Paimela, T Palosuo, K Aho, et al.
Scandinavian Journal of Rheumatology
|
January 19, 2021
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis
H B Hammer, Imj Hansen, P Järvinen, et al.
Scandinavian Journal of Rheumatology
|
July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients
H Valleala, M Korpela, T Möttönen, et al.
Annals of the Rheumatic Diseases
|
August 19, 2003
Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection
T Hannu, L Mattila, J P Nuorti, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
Immune activation in the small intestine in patients with rheumatoid arthritis
R Nissinen, M Leirisalo-Repo, A M Nieminen, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 251) with videos related to
Sort By:
Page
of 26
Clinical Rheumatology
|
June 1, 1993
Rheumatoid arthritis as a cause of cardiac compression. Favourable long-term outcome of pericardiectomy
M Hakala, T Pettersson, M Tarkka, et al.
Clinical and Experimental Immunology
|
December 1, 1991
Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix
R Lahesmaa, M Skurnik, M Vaara, et al.
Rheumatology (Oxford, England)
|
April 6, 2002
Campylobacter-triggered reactive arthritis: a population-based study
T Hannu, L Mattila, H Rautelin, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1994
Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes
M Halme, P Maasilta, H Repo, et al.
Annals of the Rheumatic Diseases
|
August 1, 1996
Clinical significance of antibodies against oxidised low density lipoprotein in early RA
L Paimela, T Helve, M Leirisalo-Repo, et al.
Annals of the Rheumatic Diseases
|
December 15, 2000
Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis
L Paimela, T Palosuo, K Aho, et al.
Scandinavian Journal of Rheumatology
|
January 19, 2021
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis
H B Hammer, Imj Hansen, P Järvinen, et al.
Scandinavian Journal of Rheumatology
|
July 9, 2009
Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients
H Valleala, M Korpela, T Möttönen, et al.
Annals of the Rheumatic Diseases
|
August 19, 2003
Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection
T Hannu, L Mattila, J P Nuorti, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
Immune activation in the small intestine in patients with rheumatoid arthritis
R Nissinen, M Leirisalo-Repo, A M Nieminen, et al.
Page
of 26